WNK1
Summary: This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
WNK lysine deficient protein kinase 1 | MIM:605232 | Ensembl:ENSG00000060237 | HGNC:HGNC:14540 | PA33782 | 12p13.33 |
GO terms in WNK1
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IEA | GO:0000287 | magnesium ion binding |
MF | IMP | GO:0004672 | protein kinase activity |
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IDA | GO:0004674 | protein serine/threonine kinase activity |
MF | TAS | GO:0004674 | protein serine/threonine kinase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IDA | GO:0005524 | ATP binding |
MF | IDA | GO:0019869 | chloride channel inhibitor activity |
MF | IEA | GO:0019870 | potassium channel inhibitor activity |
MF | IPI | GO:0019901 | protein kinase binding |
MF | IDA | GO:0019902 | phosphatase binding |
MF | IEA | GO:0030291 | protein serine/threonine kinase inhibitor activity |
MF | IMP | GO:0030295 | protein kinase activator activity |
BP | ISS | GO:0002028 | regulation of sodium ion transport |
BP | IEA | GO:0003084 | positive regulation of systemic arterial blood pressure |
BP | IBA | GO:0006468 | protein phosphorylation |
BP | IDA | GO:0006468 | protein phosphorylation |
BP | IMP | GO:0006468 | protein phosphorylation |
BP | ISS | GO:0006811 | ion transport |
BP | IDA | GO:0010923 | negative regulation of phosphatase activity |
BP | TAS | GO:0018107 | peptidyl-threonine phosphorylation |
BP | IDA | GO:0023016 | signal transduction by trans-phosphorylation |
BP | IEA | GO:0032147 | activation of protein kinase activity |
BP | IBA | GO:0032414 | positive regulation of ion transmembrane transporter activity |
BP | IBA | GO:0035556 | intracellular signal transduction |
BP | IDA | GO:0035556 | intracellular signal transduction |
BP | TAS | GO:0035556 | intracellular signal transduction |
BP | IEA | GO:0046777 | protein autophosphorylation |
BP | NAS | GO:0048666 | neuron development |
BP | ISS | GO:0050794 | regulation of cellular process |
BP | IEA | GO:0071277 | cellular response to calcium ion |
BP | IEA | GO:0071901 | negative regulation of protein serine/threonine kinase activity |
BP | IEA | GO:0090188 | negative regulation of pancreatic juice secretion |
BP | IMP | GO:0090263 | positive regulation of canonical Wnt signaling pathway |
CC | IDA | GO:0005737 | cytoplasm |
CC | IBA | GO:0005829 | cytosol |
CC | IDA | GO:0005829 | cytosol |
CC | ISS | GO:0005829 | cytosol |
CC | ISS | GO:0016020 | membrane |
Gene expression in normal tissue: WNK1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in WNK1
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-2672351 | Stimuli-sensing channels |
reactome | R-HSA-382551 | Transport of small molecules |
reactome | R-HSA-983712 | Ion channel transport |
pharmgkb | PA165984799 | Diuretics Pathway, Pharmacodynamics |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD267 | Oligomycin A | 3 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD746 | CDK9 Inhibitor | 1 |
iGMDRD505 | Pevonedistat | 3 |
iGMDRD886 | Compound 1541A | 1 |
iGMDRD246 | NPC26 | 5 |
iGMDRD414 | MST-312 | 2 |
iGMDRD652 | UNC0638 | 4 |
iGMDRD116 | CD437 | 1 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD512 | nutlin 3 | 4 |
iGMDRD486 | Tosedostat | 2 |
iGMDRD132 | (-)-gallocatechin-3-O-gallate | 2 |
iGMDRD177 | Teniposide | 2 |
iGMDRD351 | GW843682X | 4 |
iGMDRD885 | Compound 110 | 2 |
iGMDRD870 | BRD63610 | 1 |
iGMDRD255 | SB225002 | 3 |
iGMDRD802 | 4-methylfasudil | 3 |
iGMDRD138 | PX 12 | 2 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD577 | BIX01294 | 1 |
iGMDRD494 | Neopeltolide | 1 |
iGMDRD772 | BRD4770 | 5 |
iGMDRD297 | Austocystin D | 2 |
iGMDRD280 | CYTOCHALASIN B | 2 |
iGMDRD193 | Fqi1 | 4 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD77 | Itraconazole | 3 |
iGMDRD105 | Triptolide | 3 |
iGMDRD221 | Tamoxifen | 1 |
iGMDRD705 | Nakiterpiosin | 7 |
iGMDRD5 | Tyrphostin AG 1478 | 5 |
iGMDRD121 | GMX1778 | 1 |
iGMDRD137 | Indisulam | 3 |
iGMDRD158 | NSC141540 | 5 |
iGMDRD202 | Curcumin | 7 |
iGMDRD552 | AZD-1775 | 2 |
iGMDRD263 | AACOCF3 | 2 |
iGMDRD366 | PI-103 | 4 |
iGMDRD286 | Nsc 632839 | 2 |
iGMDRD871 | BRD6368 | 1 |
iGMDRD523 | Cyanoquinoline, 11 | 3 |
iGMDRD405 | PIK-75 | 2 |
iGMDRD583 | LDN 193189 | 1 |
iGMDRD584 | VER 155008 | 2 |
iGMDRD511 | CHEMBL399379 | 2 |
iGMDRD154 | NSC23766 | 6 |
iGMDRD123 | Isoevodiamine | 4 |
iGMDRD237 | ABT-751 | 1 |
iGMDRD294 | Batimastat | 5 |
iGMDRD187 | BRD9876 | 5 |
iGMDRD171 | Pemetrexed | 6 |
iGMDRD260 | FQI-2 | 1 |
iGMDRD474 | Avrainvillamide | 2 |
iGMDRD64 | Parbendazole | 4 |
iGMDRD888 | Compound 44 | 2 |
iGMDRD506 | Fedratinib | 10 |
iGMDRD188 | Piperlongumine | 5 |
iGMDRD74 | Idarubicin | 2 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD483 | SCH-529074 | 5 |
iGMDRD670 | ML 210 | 2 |
iGMDRD779 | PRL-3 Inhibitor I | 1 |
iGMDRD546 | BMS-754807 | 3 |
iGMDRD420 | Leucascandrolide A | 1 |
iGMDRD749 | ZINC6718453 | 1 |
iGMDRD425 | ERASTIN | 4 |
iGMDRD126 | Tipifarnib | 1 |
iGMDRD151 | CHM-1 | 2 |
iGMDRD466 | Chaetocin | 1 |
iGMDRD61 | Kinetin riboside | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in WNK1